The Swiss pharmaceuticals giant offered 88% above AveXis’s closing price on Friday.
The British pharmaceutical giant expects its move to buy Novartis out of their consumer healthcare joint venture to immediately boost earnings.
Learn about the origins of Johnson & Johnson and the health care conglomerate's five largest shareholders.
One source says the company is exploring whether to enter the drug purchasing market.
Biotech stocks jump this week on news of Gilead's $12 billion acquisition of Kite Pharma Inc.
Drug stocks may be hurt by slashed sales and earnings as prices soften
Major biotech funds are struggling after a series of high-profile drug pricing scandals, but that hasn't stopped the flow of junior biotech winners. (CNAT)
Novartis licensed ECF843 eye drops outside Europe from Lubris LLC.
Ibrance got FDA approval and an expanded Indication to treat metastatic breast cancer.
Novartis has secured approval from the European Commission for its lung cancer drug combo.